Purchases and Sales Made in Q4 2024 in Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE) during Q4 2024. The information is specifically focused on institutions that hold shares of Xenon Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-137K- 84.0% |
$5.22M - $6.27M
|
26.1K
$818K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-172K- 71.63% |
$6.56M - $7.86M
|
68.1K
$2.13M
|
|
|
Feb 13, 2025
Q4 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-178K- 24.14% |
$6.78M - $8.13M
|
559K
$17.5M
|
|
|
Feb 12, 2025
Q4 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-194K- 73.77% |
$7.39M - $8.86M
|
68.9K
$2.16M
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-200K- 38.03% |
$7.61M - $9.13M
|
325K
$10.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-220K- 10.58% |
$8.41M - $10.1M
|
1.86M
$58.4M
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-296K- 24.74% |
$11.3M - $13.5M
|
900K
$28.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-344K- 42.05% |
$13.1M - $15.7M
|
474K
$14.9M
|
|
|
Feb 13, 2025
Q4 2024
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-387K- 14.43% |
$14.8M - $17.7M
|
2.29M
$71.9M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-395K- 54.7% |
$15.1M - $18.1M
|
327K
$10.3M
|